Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2010
05/14/2010CA2741990A1 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
05/14/2010CA2741589A1 Pyrrolidines
05/14/2010CA2741500A1 Carbamate compound or salt thereof
05/14/2010CA2741332A1 (pyrrolidin-2-yl)phenyl derivatives for use in the treatment of pain
05/14/2010CA2741299A1 Isoindoline compounds for use in the treatment of cancer
05/14/2010CA2740794A1 Nilotinib hci crystalline forms
05/14/2010CA2738785A1 Oxoazetidine derivatives, process for the preparation thereof and use thereof in human medicine and in cosmetics
05/14/2010CA2738749A1 Melanocortin receptor antagonist compounds, process for preparing them and use thereof in human medicine and cosmetics
05/14/2010CA2738584A1 Melanocortin receptor modulators, process for preparing them and use thereof in human medicine and cosmetics
05/13/2010US20100121068 Process for preparing rabeprazole sodium
05/13/2010US20100121062 Slow Release of Organoboronic Acids in Cross-Coupling Reactions
05/13/2010US20100121054 Process for producing substituted methylamine compound and triazine derivative
05/13/2010US20100121052 Novel compounds for treating proliferative diseases
05/13/2010US20100121049 Indenoisoquinolinone analogs and methods of use thereof
05/13/2010US20100121048 Cyclic Amine Compound and Use Thereof for the Prophylaxis or Treatment of Hypertension
05/13/2010US20100120866 Process for producing amide compound
05/13/2010US20100120863 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
05/13/2010US20100120859 Novel case of renin inhibitors
05/13/2010US20100120858 Piperidine Derivatives
05/13/2010US20100120856 Derivatives of the Aminated Hydroxyquinoline Class For Treating Cancers
05/13/2010US20100120854 Tgf-beta inhibitors
05/13/2010US20100120852 Aroyl-piperidine derivatives and method of treating disorders induced by substance p
05/13/2010US20100120845 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
05/13/2010US20100120844 Tetrahydroisoquinoline compound
05/13/2010US20100120841 Benzimidazole compound and pharmaceutical use thereof
05/13/2010US20100120838 Compounds for the treatment of inflammatory disorders
05/13/2010US20100120817 Azonafide derived tumor and cancer targeting compounds
05/13/2010US20100120808 Spirocyclic heterocyclic derivatives and methods of their use
05/13/2010US20100120807 Compounds and compositions as modulators of gpr119 activity
05/13/2010US20100120806 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
05/13/2010US20100120784 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
05/13/2010US20100120783 Melanocortin receptor agonists
05/13/2010US20100120781 Novel Compounds for Treatment of Cancer and Disorders Associated with Angiogenesis Function
05/13/2010US20100120769 Cyclohexyl piperazinyl methanone derivatives
05/13/2010US20100120759 Azadecalin glucocorticoid receptor modulators
05/13/2010US20100120757 Pyrazolone derivatives as pde4 inhibitors
05/13/2010US20100120749 Tetrahydroindole derivatives as nadph oxidase inhibitors
05/13/2010US20100120731 3-([1,2,4]triazolo [4,3-a]pyridin-7-yl)benzamide derivatives
05/13/2010US20100120722 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
05/13/2010US20100120717 Kinase inhibitors
05/13/2010US20100120714 Substituted benzene fungicides
05/13/2010US20100119510 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
05/13/2010US20100119479 Therapeutic antiviral peptides
05/13/2010US20100117526 Novel azaindenochrysene derivative and organic light-emitting device
05/12/2010EP2184272A1 Piperazine derivative
05/12/2010EP2183243A2 Pyrazole compounds and their use as raf inhibitors
05/12/2010EP2183242A2 Pyrimidine derivatives 934
05/12/2010EP2183241A2 2-pyridine carboxamide derivatives as sodium channel modulators
05/12/2010EP2183240A2 N-aryl-n-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
05/12/2010EP2183227A1 1, 2, 4 -triazole derivatives as serotonergic modulators
05/12/2010EP2183225A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors
05/12/2010EP2183222A2 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof
05/12/2010EP2183221A1 New compounds as hsp90 inhibitors
05/12/2010EP2183219A2 N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
05/12/2010EP2183218A2 Novel b1 antagonists
05/12/2010EP2182953A2 New pyrazol derivatives
05/12/2010EP2182808A1 Pyridine compounds for inflammation and immune-related uses
05/12/2010EP2182807A1 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
05/12/2010EP2099762B1 Antibacterial quinoline derivatives
05/12/2010EP2076499B1 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators
05/12/2010EP2066318B1 Oxindole derivatives as anticancer agents
05/12/2010EP2049519B1 Cyclic derivatives as modulators of chemokine receptor activity
05/12/2010EP1564210B9 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
05/12/2010EP1373262B1 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors
05/12/2010CN1993350B Salt of benzimidazole derivative with amine, and process for producing the same
05/12/2010CN1960984B Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as MGLU5 receptor antagonists
05/12/2010CN1919844B Method for aqueous phase oxo-synthesis of iansoprazole
05/12/2010CN1867336B 1-aryl-4-substituted piperazines derivatives and pharmaceutical use thereof
05/12/2010CN1803795B Substituted piperidine compounds for use as h3 histamine receptor antagonists
05/12/2010CN1798559B Quinoline-2-one-derivatives for the treatment of airways diseases
05/12/2010CN1793138B Process for prepering aspetllinone
05/12/2010CN1713908B Aminoalkoxyindoles as 5-HT6-receptor ligands for the treatment of CNA-disorders
05/12/2010CN1642552B 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
05/12/2010CN101707863A protein kinase inhibitors and methods for using thereof
05/12/2010CN101704811A High-purity sodium rabeprazole compound
05/12/2010CN101704797A compounds effecting glucokinase
05/11/2010US7714138 Monocyclic heterocycles as kinase inhibitors
05/11/2010US7714137 2,2-Dichloro-N-[2-[3-(2-chloro-6-fluorophenyl)-5-isoxazolyl]-(4-pyridyl)]Acetamide; Hepatitis C virus
05/11/2010US7714129 Methods of preparing anhydrous aripiprazole form II
05/11/2010US7714115 18-F labelled positron emission tomography tracer compounds such as [18F]-fluorodeoxyglucose; autoclaving; microfluidics; solid phase synthesis; solution phase synthesis
05/11/2010US7714013 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
05/11/2010US7714001 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
05/11/2010US7714000 Substituted pyrrolidinones and their use as medicaments
05/11/2010US7713981 Method and compounds for inhibition of cell death
05/11/2010US7713964 Methods for treating asthmatic conditions
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010US7713954 Compositions and methods for treating cognitive disorders
05/11/2010CA2536544C 2-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2412968C Substituted pyridines as selective cyclooxygenase-2 inhibitors
05/11/2010CA2326324C Nitrogen-containing heterocyclic compound
05/06/2010WO2010051236A1 Isonicotinamide orexin receptor antagonists
05/06/2010WO2010050781A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010050577A1 Cyclohexane derivative and pharmaceutical use thereof
05/06/2010WO2010050456A1 Piperidine compound having di- or tri-arylmethyl structure
05/06/2010WO2010050191A1 1,2-diazetidin-3-one derivative and pharmaceutical agent comprising same
05/06/2010WO2010049331A1 Heterocyclic antiviral arylpyridone derivatives
05/06/2010WO2010049302A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/06/2010WO2010049146A1 Substituted spiroamines
1 ... 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 ... 1080